An assessment of the effect of haemoglobin variants on detection by faecal immunochemical tests

被引:6
作者
Carroll, Magdalen R. R. [1 ,2 ]
John, Cerin [1 ,2 ]
Mantio, Debbie [3 ]
Djedovic, Natasha K. [4 ]
Benton, Sally C. [1 ,2 ]
机构
[1] Royal Surrey Cty Hosp, NHS Bowel Canc Screening Programme Southern Hub, Guildford, Surrey, England
[2] Royal Surrey Cty Hosp, Berkshire & Surrey Pathol Serv, Guildford, Surrey, England
[3] Cent Middlesex Hosp, Doctors Lab, Haemoglobinopathy Screening Lab, London, England
[4] Northwick Pk Hosp & Clin Res Ctr, NHS Bowel Canc Screening Programme London Hub, London, England
关键词
Haemoglobin variants; faecal immunochemical tests for haemoglobin; colorectal cancer; screening;
D O I
10.1177/0004563218778716
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Faecal immunochemical tests (FIT) for haemoglobin (Hb) are being used in the investigation of colorectal cancer. These tests use antibodies raised to the globin moiety of human Hb. Where the globin structure is abnormal or reduced, it is possible that antibody binding, and thus Hb-detection may be affected. Methods Lysates prepared from whole blood samples of patients with known variants were diluted in manufacturer-specific buffer to 10, 100 and 500 g Hb/g faeces. These samples were analysed on four FIT analysers and the results compared with samples with no known variant present (normal samples). Results The results from this study show that of 20 variants tested, three showed a decrease in detection by all four analysers. These were -thalassaemia major and two fetal cord blood samples. Conclusions Of 20 common Hb variants studied, 17 did not affect detection of Hb by the FIT systems tested. Hb variants leading to a reduction in the presence of a globin chain caused a reduction in Hb detection; in such cases, cancers could be missed.
引用
收藏
页码:706 / 709
页数:4
相关论文
共 7 条
[1]   Fetal hemoglobin in sickle cell anemia [J].
Akinsheye, Idowu ;
Alsultan, Abdulrahman ;
Solovieff, Nadia ;
Duyen Ngo ;
Baldwin, Clinton T. ;
Sebastiani, Paola ;
Chui, David H. K. ;
Steinberg, Martin H. .
BLOOD, 2011, 118 (01) :19-27
[2]  
[Anonymous], 2012, SENTIFIT FOB GOLD LA
[3]   Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin? [J].
Kato, Jun ;
Hiraoka, Sakiko ;
Nakarai, Asuka ;
Takashima, Shiho ;
Inokuchi, Toshihiro ;
Ichinose, Masao .
INTESTINAL RESEARCH, 2016, 14 (01) :5-14
[4]  
National Institute for Health and Care Excellence (NICE), 2017, QUANT FAEC IMM TESTS
[5]   Impact of preanalytical factors on fecal immunochemical tests: need for new strategies in comparison of methods [J].
Rubeca, Tiziana C. X. ;
Cellai, Filippo ;
Confortini, Massimo ;
Fraser, Callum G. ;
Rapi, Stefano .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (03) :E269-E274
[6]   Colorectal cancer screening: a global overview of existing programmes [J].
Schreuders, Eline H. ;
Ruco, Arlinda ;
Rabeneck, Linda ;
Schoen, Robert E. ;
Sung, Joseph J. Y. ;
Young, Graeme P. ;
Kuipers, Ernst J. .
GUT, 2015, 64 (10) :1637-1649
[7]   Hemoglobin Variants: Biochemical Properties and Clinical Correlates [J].
Thom, Christopher S. ;
Dickson, Claire F. ;
Gell, David A. ;
Weiss, Mitchell J. .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2013, 3 (03)